These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

53 related items for PubMed ID: 8345014

  • 1. [Contribution of imipenem/cilastatin in the treatment of peritonitis: a comparative economic analysis in the case of France].
    Levy E, Levy P.
    J Chir (Paris); 1993 Apr; 130(4):200-9. PubMed ID: 8345014
    [Abstract] [Full Text] [Related]

  • 2. [Contribution of imipenem-cilastatin in the treatment of peritonitis: a comparative economical analysis in the case of France].
    Fichaux A, Akli J.
    J Chir (Paris); 1993 Oct; 130(10):441. PubMed ID: 8276916
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study].
    Rodloff AC, Laubenthal HJ, Bastian A, Bestehorn K, Büchele G, Gaus W.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Apr; 31(3):172-80. PubMed ID: 8672620
    [Abstract] [Full Text] [Related]

  • 4. [Study of the efficacy and tolerance of imipenem-cilastatin used as monotherapy for the adjuvant treatment to surgery of peritonitis. Results of a French multicenter study including 257 patients].
    Midy D, Pometan JP, Baste JC, Pajadon V.
    J Chir (Paris); 1992 Apr; 129(6-7):303-8. PubMed ID: 1474112
    [Abstract] [Full Text] [Related]

  • 5. Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin+aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections.
    Kreter B.
    Clin Ther; 1992 Apr; 14(1):110-21. PubMed ID: 1576620
    [Abstract] [Full Text] [Related]

  • 6. [Comparative study of the cost-effectiveness of initial therapy with imipenem/cilastatin in secondary peritonitis].
    Rodloff AC, Kujath P, Lünstedt B, Gaus W.
    Chirurg; 1998 Oct; 69(10):1093-100; discussion 1100. PubMed ID: 9833192
    [Abstract] [Full Text] [Related]

  • 7. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M, Stern A, Schilling J, Christen D, Roggo A, Geroulanos S.
    Drugs Exp Clin Res; 1993 Oct; 19(5):223-7. PubMed ID: 8174495
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years].
    Janvier G, Carles J.
    Ann Chir; 1993 Oct; 47(4):370-5. PubMed ID: 8352517
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness of imipenem/cilastatin (Tienam, MSD) in treating complicated infections in urology].
    Derevianko II, Nefedova LA, Lavrinova LN.
    Urologiia; 2002 Oct; (3):21-5. PubMed ID: 12180053
    [Abstract] [Full Text] [Related]

  • 10. The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection.
    Barie PS, Rotstein OD, Dellinger EP, Grasela TH, Walawander CA.
    Surg Infect (Larchmt); 2004 Oct; 5(3):269-80. PubMed ID: 15684798
    [Abstract] [Full Text] [Related]

  • 11. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI, Fung CP, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [Abstract] [Full Text] [Related]

  • 12. Use of ciprofloxacin in the treatment of hospitalized patients with intra-abdominal infections.
    Madan AK.
    Clin Ther; 2004 Oct; 26(10):1564-77. PubMed ID: 15598473
    [Abstract] [Full Text] [Related]

  • 13. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D.
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [Abstract] [Full Text] [Related]

  • 14. [Imipenem/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients].
    Pérez C, Sirham M, Labarca J, Grebe G, Lira P, Oliva J, Duhalde M, Ocqueteau M, Acuña G.
    Rev Med Chil; 1995 Mar; 123(3):312-20. PubMed ID: 8525170
    [Abstract] [Full Text] [Related]

  • 15. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW, Singh S, Johnson RH.
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [Abstract] [Full Text] [Related]

  • 16. [Peritonitis: dual treatment strategy of operation and antibiotics].
    Chirurg; 1997 Aug; 68(8 Suppl):Suppl 1-4. PubMed ID: 9378001
    [No Abstract] [Full Text] [Related]

  • 17. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
    Bartoloni A, Strohmeyer M, Corti G, Buonomini MI, Franchino L, Romanelli G, Moretti AM, De Vizzi GB, Petraglia A, Mancini P, Atzeni R, Fogliani V, Giura R, Paradisi F.
    Drugs Exp Clin Res; 1999 Aug; 25(6):243-52. PubMed ID: 10713862
    [Abstract] [Full Text] [Related]

  • 18. [Evidence-based medicine, health costs and treatment of intra-abdominal infection].
    Badía X, Brosa M, Tellado JM.
    Enferm Infecc Microbiol Clin; 1999 Aug; 17 Suppl 2():86-94. PubMed ID: 10605193
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
    McKinnon PS, Paladino JA, Grayson ML, Gibbons GW, Karchmer AW.
    Clin Infect Dis; 1997 Jan; 24(1):57-63. PubMed ID: 8994756
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.